混合球蛋白血脉动炎中的脏参与:当前的前景
Annalisa Villa1,2, Antonietta Gigante1, Chiara Pellicano1
1Department of Transitional and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185 Rome, Italy.
Journal of clinical medicine
|June 26, 2025
概括
混合型冷球蛋白血症 (MC) 涉及免疫复合体,导致血管损伤和潜在的脏问题. 管理需要采用多学科的方法,持续研究新的治疗方法,以应对具有挑战性的病例.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
背景情况:
- 结晶球蛋白血症是一种罕见的疾病,涉及在低温下沉的结晶球蛋白.
- 混合型冷球蛋白血症 (MC) 类型II和III很常见,与自身免疫性疾病或诸如C型肝炎之类的感染有关.
- 在MC中,脏参与影响30%的患者,并带来不良预后.
研究的目的:
- 提供综合性综述参与混合型低血球蛋白血症.
- 讨论最近的病理生理学,诊断和治疗MC的进展.
- 突出演变的流行病学趋势和新出现的相关条件.
主要方法:
- 文献综述侧重于病理生理学,流行病学,诊断和治疗的MC与脏参与.
- 分析当前的治疗策略,包括病因治疗,B细胞治疗和支持性护理.
- 考虑正在进行的新疗法临床试验.
主要成果:
- 免疫复合体通过免疫复合体沉积和血管炎可能导致严重的损伤.
- 型肝炎病毒的根除已经改变了MC的病因格局.
- 有效的管理包括病因治疗,针对B细胞的治疗 (例如,rituximab) 和支持性护理.
结论:
- 在MC中脏参与是一种严重的并发症,需要采用多模式治疗策略.
- 随着流行病学的变化和新的治疗选择,MC的理解和管理正在不断发展.
- 未来的研究和临床试验对于优化患有病的耐火性MC治疗至关重要.
相关概念视频
01:26Nephrotic Syndrome II : Assessment and Medical Management
25
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
25
01:24Nephrotic Syndrome I : Introduction
36
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
36
01:14Myocarditis III: Medical Management
20
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
20
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
48
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
48
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
64
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
64
01:17Pericarditis III: Medical Management
32
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
32